PAP 2024: John Hoffman Discusses the Inflation Reduction Act and Current Advocacy Efforts
March 21st 2024In an interview with Pharma Commerce Associate Editor Don Tracy, John Hoffman, Principal, Advocate for Success, LLC offers his thoughts on the Inflation Reduction Act and discusses current advocacy efforts.
Emerging Biopharma: Striving for Optimal Commercial Positioning
March 20th 2024In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, discusses the important and often missing element in strategic planning for clinical-stage companies—and ways to close that focus gap.
PAP 2024: Michael Galarraga Discusses "The State of Patient Access and Affordability”
March 20th 2024In an interview with Pharma Commerce Associate Editor Don Tracy, Michael Galarraga, LPC, ATR-BC, Pennsylvania State Representative, OutCare Health offers his thoughts on the breakout session and his experience in mental health counseling.
Merck's 21-Valent Pneumococcal Conjugate Vaccine Shows Efficacy Across Various Serotypes
The FDA previously granted priority review to a biologics license application for V116 as a single dose for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults.